Vascular dementia remains one of the most treatment-resistant forms of cognitive decline, lacking the pharmacological options available for Alzheimer's disease. A non-invasive neuromodulation approach that targets an accessible peripheral nerve while engaging multiple neuroprotective signaling cascades simultaneously could meaningfully shift how clinicians think about post-stroke cognitive care.
This preclinical study used a five-group male rat model of vascular dementia to evaluate auricular vagus nerve stimulation (aVNS) delivered at 0.6 mA, 40 Hz for four weeks. Treated animals outperformed both untreated VD controls and a group receiving aVNS combined with the adenosine A2A receptor (A2AR) antagonist SCH 58261, implicating A2AR activation as mechanistically necessary. The stimulation protocol upregulated phosphorylated PKA and the Nrf2/HO-1 antioxidant axis while suppressing neuroinflammatory cytokines IL-1β and IL-6 and reducing phosphorylated tau accumulation — a marker associated with neurofibrillary pathology. In vitro confirmation using rat brain microvascular endothelial cells treated with an A2AR agonist, with or without PKA inhibition, further validated the A2AR→PKA→Nrf2/HO-1 signaling sequence.
The mechanistic specificity here is notable: most VNS research has focused on cholinergic and adrenergic pathways, making the A2AR-Nrf2 connection a genuinely underexplored angle that could open new pharmacological synergy targets. That said, this study carries several important limitations. The all-male, rodent-only design limits generalizability considerably, particularly given sex-dependent differences in cerebrovascular biology. The VD model — likely bilateral carotid artery occlusion — replicates ischemic hypoperfusion but not the heterogeneous etiology of human vascular dementia. With only 50 animals split across five groups, statistical power is modest. The findings are incremental within the broader VNS landscape but add mechanistic granularity that human trials will need to evaluate. Translational optimism should remain cautious until replicated in larger, mixed-sex, and ideally primate models.
